Related Experiment Videos

Expression of type II iodothyronine deiodinase in brain tumors

M Murakami1, O Araki, T Morimura

  • 1First Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Japan. mmurakam@showa.gunma-u.ac.jp

Insights

Type II iodothyronine deiodinase (DII) messenger ribonucleic acid (mRNA) and activity are present in brain tumors. Their expression is linked, suggesting pretranslational regulation in these tissues.

Area of Science:

  • Neuroendocrinology
  • Molecular Biology
  • Oncology

Background:

  • Type II iodothyronine deiodinase (DII) is crucial for thyroid hormone metabolism in the brain.
  • While DII activity is known in brain tumors, DII mRNA expression remains uncharacterized.

Purpose of the Study:

  • To investigate the expression of DII mRNA and activity in human brain tumors.
  • To explore the relationship between DII mRNA levels and DII activity in these tumors.

Main Methods:

  • Analysis of DII mRNA expression using hybridization techniques.
  • Measurement of DII enzymatic activity in tumor tissue samples.
  • Study included astrocytoma, glioblastoma, and oligodendroglioma samples.

Main Results:

  • DII mRNA was detected in all tested brain tumors, with varying signal intensity.
  • DII activity was also present in all tumor samples.
  • Oligodendroglioma showed the highest levels of both DII mRNA and activity.
  • A strong positive correlation (r = 0.94, P < 0.01) was found between DII mRNA and DII activity.

Conclusions:

  • This is the first demonstration of both DII mRNA and activity expression in human brain tumors.
  • DII expression in brain tumors appears to be regulated at the pretranslational level.
  • Findings suggest a potential role for DII in brain tumor biology.

Related Concept Videos